X-101391786-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_021029.6(RPL36A):c.141C>T(p.Gly47=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00635 in 1,208,700 control chromosomes in the GnomAD database, including 18 homozygotes. There are 2,493 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0042 ( 2 hom., 141 hem., cov: 22)
Exomes 𝑓: 0.0066 ( 16 hom. 2352 hem. )
Consequence
RPL36A
NM_021029.6 synonymous
NM_021029.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.06
Genes affected
RPL36A (HGNC:10359): (ribosomal protein L36a) Cytoplasmic ribosomes, organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein, which shares sequence similarity with yeast ribosomal protein L44, belongs to the L44E (L36AE) family of ribosomal proteins. Although this gene has been referred to as ribosomal protein L44 (RPL44), its official name is ribosomal protein L36a (RPL36A). This gene and the human gene officially named ribosomal protein L36a-like (RPL36AL) encode nearly identical proteins; however, they are distinct genes. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. Naturally occurring read-through transcription occurs between this locus and the heterogeneous nuclear ribonucleoprotein H2 (H') gene. [provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant X-101391786-C-T is Benign according to our data. Variant chrX-101391786-C-T is described in ClinVar as [Benign]. Clinvar id is 708163.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-101391786-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-1.06 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RPL36A | NM_021029.6 | c.141C>T | p.Gly47= | synonymous_variant | 3/5 | ENST00000553110.8 | |
RPL36A-HNRNPH2 | NM_001199973.2 | c.141C>T | p.Gly47= | synonymous_variant | 3/5 | ||
RPL36A-HNRNPH2 | NM_001199974.2 | c.141C>T | p.Gly47= | synonymous_variant | 3/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RPL36A | ENST00000553110.8 | c.141C>T | p.Gly47= | synonymous_variant | 3/5 | 1 | NM_021029.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00421 AC: 470AN: 111760Hom.: 2 Cov.: 22 AF XY: 0.00416 AC XY: 141AN XY: 33916
GnomAD3 genomes
AF:
AC:
470
AN:
111760
Hom.:
Cov.:
22
AF XY:
AC XY:
141
AN XY:
33916
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00407 AC: 738AN: 181291Hom.: 2 AF XY: 0.00393 AC XY: 259AN XY: 65843
GnomAD3 exomes
AF:
AC:
738
AN:
181291
Hom.:
AF XY:
AC XY:
259
AN XY:
65843
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00657 AC: 7204AN: 1096883Hom.: 16 Cov.: 31 AF XY: 0.00649 AC XY: 2352AN XY: 362297
GnomAD4 exome
AF:
AC:
7204
AN:
1096883
Hom.:
Cov.:
31
AF XY:
AC XY:
2352
AN XY:
362297
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00420 AC: 470AN: 111817Hom.: 2 Cov.: 22 AF XY: 0.00415 AC XY: 141AN XY: 33983
GnomAD4 genome
AF:
AC:
470
AN:
111817
Hom.:
Cov.:
22
AF XY:
AC XY:
141
AN XY:
33983
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 29, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at